Elutia (ELUT) Revenue Growth (3y) (2022 - 2026)
Elutia (ELUT) Revenue Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.32 Bn | 177.02 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 68.65 Bn | 67.20 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 47.43 Bn | 43.76 Bn | 1.29 Bn | 10.52% |
| 6 | GE HealthCare Technologies | 28.48 Bn | 26.19 Bn | 1.98 Bn | 2.92% |
| 7 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | 17.14% |
| 8 | Smith & Nephew | 26.98 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | 0.73% |
| 10 | Elutia | 39.47 Mn | 10.98 Mn | 1.80 Mn | -21.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.31% |
| Dec 31, 2025 | -20.81% |
| Sep 30, 2025 | -17.18% |
| Jun 30, 2025 | -20.87% |
| Mar 31, 2025 | -36.44% |
| Dec 31, 2024 | -36.23% |
| Sep 30, 2024 | -31.68% |
| Jun 30, 2024 | -19.72% |
| Mar 31, 2024 | -19.61% |
| Dec 31, 2023 | -22.18% |
| Sep 30, 2023 | -19.57% |
| Jun 30, 2023 | -9.54% |
| Mar 31, 2023 | -13.46% |
| Dec 31, 2022 | -18.24% |
| Sep 30, 2022 | -19.32% |